Author: vicky
Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
Certara improves software capabilities by expanding into deep learning and data fabric PRINCETON, N.J.— January 4, 2023 — Certara, Inc. (Nasdaq: CERT), today announced it has acquired Vyasa Analytics, LLC. Vyasa provides scalable deep-learning software which allows life sciences organizations to perform predictions and answer complex questions across structured and unstructured bio-medical information. The acquisition will elevate Certara’s software by bringing state-of-the-art artificial intelligence (AI) capabilities to its end-to-end platform. “We are pleased to … Continued
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare … Continued
Project Optimus: How to engage with the FDA to advance your program
Join us for this SPECIAL SESSION taking place during DIA Global 2022. This is a cocktail reception with presentation and Q&A hosted by Julie Bullock, PharmD & ex FDA and Demetrius Carter at the Hyatt Regency McCormick Place. Given the launch of Project Optimus, how do you best navigate the evolving regulatory landscape and determine … Continued
PharmaSUG 2022: May 22-25 in Austin, TX
Prediction of drug-drug interactions with oxycodone and pupil constriction using a physiologically based pharmacokinetic-pharmacodynamic model
TOPRA Regulatory Careers Live – 2022
Quantitative Systems Pharmacology Conference (QSPC2022)
Accelerating Pediatric Drug Development: Regulatory and Industry Perspectives
Certara, University of Cape Town and Pharmacometrics Africa Partner on Fellowship Program in Africa for Applied Pharmacometrics Training
PRINCETON, N.J.— March 29, 2022 — Certara, Inc, a global leader in biosimulation, and Pharmacometrics Africa NPC, today announced a partnership with the University of Cape Town (UCT) to support its fellowship program for doctoral-level scientists from Africa. The Fellowship program builds scientific and leadership capability in the region by enhancing the skills of scientists and … Continued